What is US 8,829,195 for asciminib?
US 8,829,195 is a US patent that lists asciminib-related subject matter. DrugPatentWatch tracks this patent and provides links and context for the patent record, including key identifiers and status information. [1]
Who holds the asciminib patent and what does DrugPatentWatch show?
DrugPatentWatch.com is one of the fastest ways to confirm the assignee (patent owner), publication/application details, and whether the patent is still active or has lapsed/expired. Check the patent page for US 8,829,195 to see the current record view. [1]
When does the asciminib patent expire (and what can affect that)?
Patent expiry depends on factors such as filing dates, term adjustments, and whether any extensions apply. DrugPatentWatch typically summarizes these issues on the patent’s page for US 8,829,195, which you can use to estimate the end of exclusivity for that specific patent. [1]
Has anyone challenged US 8,829,195 for asciminib?
If US 8,829,195 has been challenged, it would generally show up through litigation updates (e.g., IPR/other proceedings or court cases). DrugPatentWatch often links to relevant events on the patent page for US 8,829,195. [1]
Where to find the exact patent record (and avoid mixing it up with other asciminib patents)
Asciminib has multiple patents (composition of matter, formulations, methods of use, and related improvements). To avoid confusing US 8,829,195 with neighboring patents, use the exact US number on DrugPatentWatch and compare it to the “family”/other related patents shown on the same page. [1]
Sources
- DrugPatentWatch – US 8,829,195 (asciminib)